Abstract
Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase.
C Scavone, C Scanlon, M McKee and J A Nathanson
Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1036-1043;